List of bibliographic references
Number of relevant bibliographic references: 34.
[0-20] [
0 - 20][
0 - 34][
20-33][
20-40]
Ident. | Authors (with country if any) | Title |
---|
003915 (2001) |
| Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. |
003916 (2001) |
| [177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients. |
003B02 (2000) |
| Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy. |
003B86 (2000) |
| Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma. |
003D58 (2000) |
| The role of radioactive somatostatin and its analogues in the control of tumor growth. |
003D61 (1999) |
| Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. |
003D68 (1999) |
| Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide. |
003E56 (1999) |
| Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. |
003E58 (1999) |
| Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount. |
003E86 (1999) |
| Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake. |
004113 (1998) |
| Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. |
004202 (1998) |
| Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. |
004203 (1998) |
| Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy. |
004221 (1997) |
| D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. |
004222 (1997) |
| Radiation dosimetry for indium-111-pentetreotide. |
004225 (1997) |
| Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats. |
004394 (1997) |
| Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy. |
004541 (1996) |
| Studies on radiolabeled somatostatin analogues in rats and in patients. |
004603 (1996) |
| Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. |
004757 (1996) |
| Permeability of human isolated airways increases after hydrogen peroxide and poly-L-arginine. |
004802 (1996) |
| In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i -k "W H Bakker"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i \
-Sk "W H Bakker" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Curation
|type= indexItem
|index= Author.i
|clé= W H Bakker
}}
| This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024 |  |